The Language of Genomics

Barry Schuler Genomics 101

The experiments are described in the journal Science Translational Medicine.

There are two key challenges in genomics.

Juan Enriquez on genomics and our future

Consumer applications for genomics, they will flourish.

At NIH, we have started this new National Center for Advancing Translational Sciences.

They represent the maximum symmetry a structure with the translational symmetry concerned can have.

I first met him through the Archon X PRIZE for Genomics.

Complete Genomics and its competitors are about to create huge amounts of data.

Companies such as Complete Genomics are developing software that can process the information.

Synthetic Genomics has a 600 million agreement with ExxonMobil to obtain fuel from algae.

If we understand biology from genomics and omics and wireless through physiologic phenotyping, that's big.

What Complete Genomics is doing with the 91 million it has raised so far is exciting.

DALIAN, CHINA Last week, a company called Complete Genomics announced 10 new customers for its genome sequencing service.

In the field of genetics and genomics, it aids in sequencing and annotating genomes and their observed mutations.

Genome annotation In the context of genomics, annotation is the process of marking the genes and other biological features in a DNA sequence.

So the blind alley of gene therapy has sent biotechnology heading full throttle down the road of drug development, based on the new genomics.

This company, Synthetic Genomics, I'm involved with, created the first full synthetic genome for a little bug, a very primitive creature called Mycoplasma genitalium.

The US continues to excel, with huge recent breakthroughs in Mars exploration and genomics, though it is now imperiling that excellence through budget cuts.

These include the comparisons of DNA sequences conducted within molecular biology or genomics, and comparisons of fossils or other records of ancient organisms in paleontology.

What's happening in genomics, and how this revolution is about to change everything we know about the world, life, ourselves, and how we think about them.

Finally, of course, we have the spectacular advances in our knowledge of genomics, the science that lets us understand the basic mechanisms that operate inside all living systems, including humans.

Their report contains substantial corrections of the genome map generated a year earlier by the high tech DNA sequencing efforts of Celera Genomics, Inc. and a large public consortium of labs.

Scientific discoveries, futurist Juan Enriquez notes, demand a shift in code, and our ability to thrive depends on our mastery of that code. Here, he applies this notion to the field of genomics.

What Complete Genomics is doing with the 91 million it has raised so far is exciting. It has built a genome sequencing factory and plans to build several more over the next few years.

First, major advances in our knowledge of genomics specifically, the way diseases manifest and develop in the body at the genetic level are improving our ability to target illness at each stage and improve the patient experience.

In an age of intense technological competition, countries that combine public and private research and development (R D) financing are outpacing the rest. The US continues to excel, with huge recent breakthroughs in Mars exploration and genomics, though it is now imperiling that excellence through budget cuts.

He has been criticized for the fact that the research was funded by Synthetic Genomics, a company that he cofounded, which will hold the intellectual property rights resulting from the research and has already filed for 13 patents related to it. But the work has taken 20 scientists a decade to complete, at an estimated cost of 40 million, and commercial investors are an obvious source for such funds.

Its findings are based on applying traditional gene mapping strategies to humans, making use of Iceland's unique historical circumstances of having a relatively isolated population, derived from a small founder group, with little immigration and extensive genealogical records. Their report contains substantial corrections of the genome map generated a year earlier by the high tech DNA sequencing efforts of Celera Genomics, Inc. and a large public consortium of labs.